Hi Europe & Ni, 2-4 December 2014
- Place：Amsterdam, The Netherlands
- Booth No：K84
Meet Us at SupplySide West 2016 in Las Vegas (USA) during October 6-7 and Hi Europe & Ni 2016 in Frankfurt (Germany) during November 29-December 1
This year, we are going to exhibit at SupplySide West 2016 in Las Vegas during October 6-7 and Hi Europe & Ni 2016 in Frankfurt during November 29-December 1. Here you will see our multi-functional dietary ingredients － ANKASCIN 568-R and Vigiis 101-Probiotic. ANKASCIN 568-R has been completed in aspects of health benefits, safety, legality, and identity for quality assurance. During the exhibitions, we will share the information on our New Dietary Ingredient document issued by the US FDA as well as two clinical trials on blood lipid and blood sugar control. You are very welcome to visit us at SupplySide West 2016 Hi Europe & Ni 2016 Las Vegas, USA Frankfurt, Germany […]
This year, we are going to exhibit at SupplySide West 2017 in Las Vegas during September 27-28. Here you will see our multi-functional dietary ingredients － ANKASCIN 568-R and Vigiis 101-LAB.
According to the World Health Organization (WHO), cardiovascular disease (CVD) is the leading cause of death globally. Some of the risk factors for CVD include high cholesterol, hypertension and diabetes. Red yeast rice has been shown to help lower cholesterol and improve blood circulation, as well as positively impacting blood lipids, blood glucose and blood pressure. This Whitepaper by SunWay Biotech Co. Ltd. explores the potential of ANKASCIN® 568-R red yeast rice extract—which does not contain monacolin K (statin)—in heart health dietary supplement applications. • The CDC attributes one-quarter of American deaths annually to CVD, with no gender bias. • U.S. sales of red yeast rice dietary supplements were estimated at $49 million in 2015. • The U.S. heart health ingredient market is predicted to reach $15.2 billion by 2018 Source: Natural Products Insider